South Korea Hormone Replacement Therapy Market Size, Share, and COVID-19 Impact Analysis, By Product (Estrogen & Progesterone Replacement Therapy, HGH Replacement Therapy, Thyroid Hormone Replacement Therapy, Testosterone Replacement Therapy, and Parathyroid Hormone Replacement), By Route od Administration (Oral, Parenteral, Transdermal, and Others), and South Korea Hormone Replacement Therapy Market Insights, Industry Trend, Forecasts to 2035.

South Korea Hormone Replacement Therapy Market Insights Forecasts to 2035

• The South Korea Hormone Replacement Therapy Market Size Was Estimated at USD 171.96 Million in 2024
• The Market Size is Expected to Grow at a CAGR of Around 5.19% from 2025 to 2035
• The South Korea Hormone Replacement Therapy Market Size is Expected to Reach USD 299.97 Million by 2035

According to a research report published by Spherical Insights & Consulting, The South Korea Hormone Replacement Therapy Market is anticipated to reach USD 299.97 Million by 2035, growing at a CAGR of 5.19% from 2025 to 2035. The South Korean hormone replacement therapy market is driven by rising prevalence of menopause and related hormonal disorders, increasing awareness of HRT benefits, and growing geriatric population.

Market Overview

The South Korean hormone replacement therapy market focuses on the development, production, distribution, and sale of hormone-based treatments. Hormone replacement therapy is a medical treatment in which hormones, usually estrogen and progesterone, are given to augment the body's natural hormone levels. It is primarily used to relieve symptoms of menopause, perimenopause, or other hormonal imbalances, such as hot flashes, mood swings, osteoporosis, and vaginal dryness. In South Korea, increasing health awareness and shifting societal perspectives are boosting demand for hormone replacement therapy. Urban women are increasingly seeking hormone replacement therapy to treat menopausal symptoms such as hot flashes and mood swings. Wellness-focused clinics in places like Seoul and Busan provide integrated treatment, integrating hormone therapy with lifestyle advice, food, and exercise, making HRT more popular and driving market development. The rising demand for personalized medicines is a key trend for this market, and this trend presents a prominent opportunity for growth in South Korea.

Report Coverage

This research report categorizes the market for the south Korea hormone replacement therapy market based on various segments and regions and forecasts revenue growth and analyses trends in each submarket. The report analyses the key growth drivers, opportunities, and challenges influencing the south Korea hormone replacement therapy market. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key market players and analyses their core competencies in each sub-segment of the south Korea hormone replacement therapy market.

Driving Factors

The rising prevalence of menopause is one of the major contributors to this market. In South Korea, women are becoming more informed about menopause symptoms and HRT benefits. The availability of clinics that provide tailored, holistic menopause care is propelling the South Korean HRT industry, encouraging more women to take hormone replacement therapy. Telemedicine and online health platforms are propelling the South Korean HRT industry by increasing access, patient education, and adherence to hormone replacement treatment. Additionally, advancements in formulations play a vital role in market expansion.

Restraining Factors

The high prices of branded HRT medications and clinic visits limit the adoption among price-sensitive patients. Additionally, strict guidelines on hormone therapies can delay product availability.

Market Segmentation

The South Korea hormone replacement therapy market share is classified into product and route of administration.

• The estrogen & progesterone replacement therapy segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The south Korea hormone replacement therapy market is segmented by product into estrogen & progesterone replacement therapy, high replacement therapy, thyroid hormone replacement therapy, testosterone replacement therapy, and parathyroid hormone replacement. Among these, the estrogen & progesterone replacement therapy segment held the largest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This is due to high demand for treatments addressing menopausal symptoms. A rising population of women suffering from hot flashes, osteoporosis, and sleep difficulties has resulted in persistent usage of these medicines.

• The oral segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period.

The south Korea hormone replacement therapy market is segmented by route of administration into oral, parenteral, transdermal, and others. Among these, the oral segment held the highest share in 2024 and is expected to grow at a significant CAGR during the forecast period. This segmental growth is attributed to its ease of use and patient convenience. Additionally, Oral formulations of estrogen, progesterone, and thyroid hormones are still commonly recommended in healthcare.

Competitive Analysis:

The report offers the appropriate analysis of the key organizations/companies involved within the South Korea hormone replacement therapy market, along with a comparative evaluation primarily based on their product offering, business overviews, geographic presence, enterprise strategies, segment market share, and SWOT analysis. The report also provides an elaborative analysis focusing on the current news and developments of the companies, which includes product development, innovations, joint ventures, partnerships, mergers & acquisitions, strategic alliances, and others. This allows for the evaluation of the overall competition within the market.

List of Key Companies

• Celltrion Inc.
• Eli Lilly and Company
• Bayer AG
• Pfizer Inc.
• Merck & Co., Inc.
• Viatris, Inc.
• Novo Nordisk A/S
• F. Hoffmann-La Roche Ltd.
• Hisamitsu Pharmaceutical Co., Inc.
• Abbott
• Roche Holding AG

Recent Development

• In May 2025, Daewon Pharmaceutical partners with Bayer Korea to exclusively market and distribute HRT products Angeliq and Climen, boosting South Korea’s menopause therapy market.

Key Target Audience

• Market Players
• Investors
• End-users
• Government Authorities 
• Consulting and Research Firm
• Venture capitalists
• Value-Added Resellers (VARs)

Market Segment

This study forecasts revenue at South Korea, regional, and country levels from 2020 to 2035. Spherical Insights has segmented the south Korea hormone replacement therapy market based on the below-mentioned segments:

South Korea Hormone Replacement Therapy Market, By product

• Estrogen & Progesterone Replacement Therapy
• HGH Replacement Therapy
• Thyroid Hormone Replacement Therapy
• Testosterone Replacement Therapy
• Parathyroid Hormone Replacement

South Korea Hormone Replacement Therapy Market, By Route of Administration

• Oral
• Parenteral
• Transdermal
• Others